Drugs / [177Lu]Lu-BQ7876
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06641219 | Oct → Dec 2024 | prostate cancer | Tomsk National Research Medical Center of the Russian Academy of Sciences | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [177Lu]Lu-BQ7876 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06641219 ↗ |
| Modality | Diagnostic / imaging agent | “in a diagnostic dosage” NCT06641219 ↗ |
| Route | Intravenous | “single intravenous injection” NCT06641219 ↗ |